BranchOut Food Inc., a company specializing in plant-based dried fruit and vegetable snacks, has started an underwritten public offering of its common stock to raise capital. The company plans to use the proceeds for working capital, operating expenses, and capital expenditures. Lake Street Capital Markets is managing the offering, which includes a 30-day option to buy additional shares to cover over-allotments. The offering is subject to market conditions, and details will be available in a prospectus filed with the SEC.
BranchOut Food Inc. public offering news is context for readers. For those following Consumer Staples, here is Pluang's market snapshot as of Oct 23, 2026 03:02 WIB: 56 of 63 US Consumer Staples stocks rose today. Boston Beer Company Inc (SAM) gained 7.64% to USD 195.70 with a 60-day typical hold time. General Mills, Inc. (GIS) rose 7.55% to USD 35.03, held typically for 108 days. Conagra Brands Inc (CAG) increased 7.44% to USD 15.09, with a 97-day hold time.
Remittix has raised $33 million in its presale, nearing its $36 million hard cap ahead of its November 24, 2026 launch. The project offers a PayFi ecosystem connecting crypto with bank payments, with active product use and testing underway. Meanwhile...
Share-ify introduced the S.A.F.E. Score™, an AI-powered forecasting engine designed to enhance supplier risk intelligence within its food safety and compliance solutions. This tool analyzes diverse data such as audit results, recall history, and insp...
EquipmentShare, a major U.S. construction equipment rental and technology provider, will announce its fiscal third quarter 2026 financial results after market close on November 9, 2026. The company will host a conference call for investors and analys...
Atlantic American Corporation received a Nasdaq Staff Delisting Determination due to missing its 2025 annual and 2026 quarterly SEC reports by the extended October 12 deadline. The company has since filed the 2025 annual report and is working to subm...
Lycia Therapeutics, a biotech company developing therapies targeting disease-causing proteins, priced its upsized initial public offering at $18 per share, raising approximately $317.5 million before expenses. The company plans to use the funds to ad...
